Your browser doesn't support javascript.
loading
Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers.
Fagnan, Alexandre; Bagger, Frederik Otzen; Piqué-Borràs, Maria-Riera; Ignacimouttou, Cathy; Caulier, Alexis; Lopez, Cécile K; Robert, Elie; Uzan, Benjamin; Gelsi-Boyer, Véronique; Aid, Zakia; Thirant, Cécile; Moll, Ute; Tauchmann, Samantha; Kurtovic-Kozaric, Amina; Maciejewski, Jaroslaw; Dierks, Christine; Spinelli, Orietta; Salmoiraghi, Silvia; Pabst, Thomas; Shimoda, Kazuya; Deleuze, Virginie; Lapillonne, Hélène; Sweeney, Connor; De Mas, Véronique; Leite, Betty; Kadri, Zahra; Malinge, Sébastien; de Botton, Stéphane; Micol, Jean-Baptiste; Kile, Benjamin; Carmichael, Catherine L; Iacobucci, Ilaria; Mullighan, Charles G; Carroll, Martin; Valent, Peter; Bernard, Olivier A; Delabesse, Eric; Vyas, Paresh; Birnbaum, Daniel; Anguita, Eduardo; Garçon, Loïc; Soler, Eric; Schwaller, Juerg; Mercher, Thomas.
Afiliação
  • Fagnan A; Unité 1170 (U1170), INSERM, Gustave Roussy, Université Paris Diderot, Villejuif, France.
  • Bagger FO; Equipe Labellisée Ligue Nationale Contre le Cancer, Paris, France.
  • Piqué-Borràs MR; University Children's Hospital Beider Basel (UKBB), Basel, Switzerland.
  • Ignacimouttou C; Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Caulier A; Center for Genomic Medicine, Copenhagen University Hospital, Copenhagen, Denmark.
  • Lopez CK; Swiss Institute of Bioinformatics, Basel, Basel, Switzerland.
  • Robert E; University Children's Hospital Beider Basel (UKBB), Basel, Switzerland.
  • Uzan B; Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Gelsi-Boyer V; Unité 1170 (U1170), INSERM, Gustave Roussy, Université Paris Diderot, Villejuif, France.
  • Aid Z; Equipe Labellisée Ligue Nationale Contre le Cancer, Paris, France.
  • Thirant C; Equipe d'Accueil (EA) 4666, Hématopoïèse et Immunologie (HEMATIM), Université de Picardie Jules Verne (UPJV), Amiens, France.
  • Moll U; Service Hématologie Biologique, Centre Hospitalier Universitaire (CHU) Amiens, Amiens, France.
  • Tauchmann S; Unité 1170 (U1170), INSERM, Gustave Roussy, Université Paris Diderot, Villejuif, France.
  • Kurtovic-Kozaric A; Equipe Labellisée Ligue Nationale Contre le Cancer, Paris, France.
  • Maciejewski J; Unité 1170 (U1170), INSERM, Gustave Roussy, Université Paris Diderot, Villejuif, France.
  • Dierks C; Equipe Labellisée Ligue Nationale Contre le Cancer, Paris, France.
  • Spinelli O; Unité Mixte de Recherche 967 (UMR 967), INSERM-Commissariat à l'Énergie Atomique et aux Énergies Alternatives (CEA)/Direction de la Recherche Fondamentale (DRF)/Institut de Biologie François Jacob (IBFJ)/Institut de Radiobiologie Cellulaire et Moléculaire (IRCM)/Laboratoire des cellules Souches Héma
  • Salmoiraghi S; U1068 and.
  • Pabst T; UMR7258, Centre de Recherche en Cancérologie de Marseille, Centre National de la Recherche Scientifique (CNRS)/INSERM/Institut Paoli Calmettes/Aix-Marseille Université, Marseille, France.
  • Shimoda K; Unité 1170 (U1170), INSERM, Gustave Roussy, Université Paris Diderot, Villejuif, France.
  • Deleuze V; Equipe Labellisée Ligue Nationale Contre le Cancer, Paris, France.
  • Lapillonne H; Unité 1170 (U1170), INSERM, Gustave Roussy, Université Paris Diderot, Villejuif, France.
  • Sweeney C; Equipe Labellisée Ligue Nationale Contre le Cancer, Paris, France.
  • De Mas V; Institute of Molecular Oncology, University Medical Center Göttingen, Göttingen, Germany.
  • Leite B; Department of Pathology, Stony Brook University, Stony Brook, NY.
  • Kadri Z; University Children's Hospital Beider Basel (UKBB), Basel, Switzerland.
  • Malinge S; Department of Biomedicine, University of Basel, Basel, Switzerland.
  • de Botton S; Clinical Center of the University of Sarajevo, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
  • Micol JB; Department of Translational Hematology and Oncologic Research, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.
  • Kile B; Hämatologie, Onkologie und Stammzelltransplantation, Klinik für Innere Medizin I, Freiburg, Germany.
  • Carmichael CL; UOC Ematologia, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Iacobucci I; UOC Ematologia, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Mullighan CG; FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Carroll M; Department of Oncology, Inselspital, University Hospital Bern/University of Bern, Bern, Switzerland.
  • Valent P; Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
  • Bernard OA; IGMM, University of Montpellier, CNRS, Montpellier, France.
  • Delabesse E; Université de Paris, Laboratory of Excellence GR-Ex, Paris, France.
  • Vyas P; Centre de Recherche Saint Antoine (CRSA)-Unité INSERM, Sorbonne Université/Assistance Publique-Hôpitaux de Paris (AP-HP)/Hôpital Trousseau, Paris, France.
  • Birnbaum D; Medical Research Council Molecular Haematology Unit (MRC MHU), Biomedical Research Centre (BRC) Hematology Theme, Oxford Biomedical Research Centre, Oxford Centre for Haematology, Weatherall Institute of Molecular Medicine (WIMM), Radcliffe Department of Medicine, University of Oxford, Oxford, Unite
  • Anguita E; Team 16, Hematology Laboratory, Center of Research of Cancerology of Toulouse, U1037, INSERM/Institut Universitaire du Cancer de Toulouse (IUCT) Oncopole, Toulouse, France.
  • Garçon L; Genomic Platform, Unité Mixte de Service - Analyse Moléculaire, Modélisation et Imagerie de la maladie Cancéreuse (UMS AMMICA), Gustave Roussy/Université Paris-Saclay, Villejuif, France.
  • Soler E; Division of Innovative Therapies, UMR-1184, Immunologie des Maladies Virales, Auto-immunes, Hématologiques et Bactériennes (IMVA-HB) and Infectious Disease Models and Innovative Therapies (IDMIT) Center, CEA/INSERM/Paris-Saclay University, Fontenay-aux-Roses, France.
  • Schwaller J; Unité 1170 (U1170), INSERM, Gustave Roussy, Université Paris Diderot, Villejuif, France.
  • Mercher T; Telethon Kids Institute, Perth Children's Hospital, Nedlands, WA, Australia.
Blood ; 136(6): 698-714, 2020 08 06.
Article em En | MEDLINE | ID: mdl-32350520
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Fatores de Transcrição / Leucemia Eritroblástica Aguda / Transcriptoma / Proteínas de Neoplasias Tipo de estudo: Prognostic_studies Idioma: En Revista: Blood Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Fatores de Transcrição / Leucemia Eritroblástica Aguda / Transcriptoma / Proteínas de Neoplasias Tipo de estudo: Prognostic_studies Idioma: En Revista: Blood Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França